| Source: |
| Type: |
| Power to enhance an anti cancer effect |
| 4384- | , | Silver nanoparticles: synthesis, properties, and therapeutic applications |
| - | Review, | Var, | NA |
| 2325- | 2DG, | Research Progress of Warburg Effect in Hepatocellular Carcinoma |
| - | Review, | Var, | NA |
| 1340- | 3BP, | Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study |
| - | Review, | NA, | NA |
| 1341- | 3BP, | The HK2 Dependent “Warburg Effect” and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-Bromopyruvate |
| - | Review, | NA, | NA |
| 5282- | 3BP, | Rad, | 3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-468 |
| 5278- | 3BP, | effect-of-3-bromopyruvate-on-human-colorectal">The effect of 3-bromopyruvate on human colorectal cancer cells is dependent on glucose concentration but not hexokinase II expression |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | Caco-2 | - | in-vitro, | CRC, | SW48 |
| 5274- | 3BP, | ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1 |
| - | in-vitro, | PC, | NA |
| 5272- | 3BP, | The efficacy of the anticancer 3-bromopyruvate is potentiated by antimycin and menadione by unbalancing mitochondrial ROS production and disposal in U118 glioblastoma cells |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | Nor, | HEK293 |
| 5263- | 3BP, | CET, | 3-Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy-dependent ferroptosis |
| - | in-vitro, | CRC, | DLD1 | - | NA, | NA, | HCT116 |
| 5259- | 3BP, | Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP |
| - | in-vivo, | HCC, | NA |
| 5260- | 3BP, | Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer |
| - | in-vivo, | PC, | NA |
| 5261- | 3BP, | The cytotoxicity of 3-bromopyruvate in breast cancer cells depends on extracellular pH |
| - | in-vitro, | BC, | NA |
| 5269- | 3BP, | The anti-metabolite KAT/3BP has in vitro and in vivo anti-tumor activity in lymphoma models. |
| - | in-vitro, | HCC, | NA |
| 5264- | 3BP, | Candidate cancer drug suspected after death of three patients at an alternative medicine clinic |
| - | Review, | Var, | NA |
| 5266- | 3BP, | 3-bromopyruvate-based agent KAT-101 |
| - | Review, | Var, | NA |
| - | in-vitro, | CRC, | NA |
| 3941- | 5HT, | dietMed, | VitB12, | FA, | VitC | Nutrition strategies that improve cognitive function |
| - | Review, | AD, | NA |
| 3968- | ACNs, | Enhanced Neuronal Activation with Blueberry Supplementation in Mild Cognitive Impairment |
| - | Human, | AD, | NA |
| 3973- | ACNs, | Saskatoon and wild blueberries have higher anthocyanin contents than other Manitoba berries |
| - | Analysis, | AD, | NA |
| 5459- | AF, | Auranofin Induces Lethality Driven by Reactive Oxygen Species in High-Grade Serous Ovarian Cancer Cells |
| - | in-vitro, | Ovarian, | NA |
| 5460- | AF, | Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species |
| - | vitro+vivo, | Var, | 4T1 |
| 5469- | AF, | Ligand supplementation restores the cancer therapy efficacy of the antirheumatic drug auranofin from serum inactivation |
| - | in-vitro, | CRC, | HCT116 |
| 5468- | AF, | The gold complex auranofin: new perspectives for cancer therapy |
| - | Review, | Var, | NA |
| - | in-vitro, | Lung, | NA |
| 1900- | AF, | Potential Anticancer Activity of Auranofin |
| - | Review, | Var, | NA |
| 5444- | AG, | A Systematic Review of Phytochemistry, Pharmacology and Pharmacokinetics on Astragali Radix: Implications for Astragali Radix as a Personalized Medicine |
| - | Review, | Var, | NA |
| 5431- | AG, | Advances in research on the anti-tumor mechanism of Astragalus polysaccharides |
| - | Review, | Var, | NA |
| 5432- | AG, | Astragalus polysaccharides combined with radiochemotherapy for cervical cancer: a systematic review and meta-analysis of randomized controlled studies |
| - | Review, | Cerv, | NA |
| 5434- | AG, | Recent Advances in the Mechanisms and Applications of Astragalus Polysaccharides in Liver Cancer Treatment: An Overview |
| - | Review, | Liver, | NA |
| 5441- | AG, | Chemo, | Astragalus-containing Chinese herbal combinations for advanced non-small-cell lung cancer: a meta-analysis of 65 clinical trials enrolling 4751 patients |
| - | Review, | Lung, | NA |
| 5975- | AgNPs, | PDT, | CDT, | RF, | Recent Advances in the Application of Silver Nanoparticles for Enhancing Phototherapy Outcomes |
| - | Review, | Var, | NA | - | Review, | BPH, | NA |
| 5976- | AgNPs, | Review on Harnessing Silver Nanoparticles for Therapeutic Innovations: A Comprehensive Review on Medical Applications, Safety, and Future Directions |
| - | Review, | Vit, | NA |
| 5977- | AgNPs, | CDT, | Silver Nitroprusside as an Efficient Chemodynamic Therapeutic Agent and a Peroxynitrite nanogenerator for Targeted Cancer Therapy |
| - | in-vivo, | Ovarian, | A2780S | - | NA, | Ovarian, | SKOV3 |
| 4403- | AgNPs, | Silver Nanoparticles Decorated UiO-66-NH2 Metal-Organic Framework for Combination Therapy in Cancer Treatment |
| - | in-vitro, | GBM, | U251 | - | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | GL26 | - | in-vitro, | Cerv, | HeLa | - | in-vitro, | CRC, | RKO |
| 4404- | AgNPs, | Rad, | Main Approaches to Enhance Radiosensitization in Cancer Cells by Nanoparticles: A Systematic Review |
| - | Review, | Var, | NA |
| 4400- | AgNPs, | Rad, | Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Nor, | MCF10 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | BT549 | - | in-vivo, | BC, | MDA-MB-231 |
| 4399- | AgNPs, | Chit, | Silver nanoparticles impregnated alginate-chitosan-blended nanocarrier induces apoptosis in human glioblastoma cells |
| - | in-vitro, | GBM, | U87MG |
| 4398- | AgNPs, | Induction of apoptosis in cancer cells at low silver nanoparticle concentrations using chitosan nanocarrier |
| - | in-vitro, | Colon, | HT29 |
| 4423- | AgNPs, | Pongamia pinnata seed extract-mediated green synthesis of silver nanoparticle loaded nanogel for estimation of their antipsoriatic properties |
| - | in-vivo, | PSA, | NA |
| 4424- | AgNPs, | Understanding the prospective of nano-formulations towards the treatment of psoriasis |
| - | in-vivo, | PSA, | NA |
| 4415- | AgNPs, | SDT, | CUR, | Examining the Impact of Sonodynamic Therapy With Ultrasound Wave in the Presence of Curcumin-Coated Silver Nanoparticles on the Apoptosis of MCF7 Breast Cancer Cells |
| - | in-vitro, | BC, | MCF-7 |
| 4413- | AgNPs, | Anzaroot, | Green synthesis of silver nanoparticles from plant Astragalus fasciculifolius Bioss and evaluating cytotoxic effects on MCF7 human breast cancer cells |
| - | in-vitro, | BC, | MCF-7 |
| 4412- | AgNPs, | Biosynthesis and characterization of silver nanoparticles from Asplenium dalhousiae and their potential biological properties |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | Melanoma, | A2780S |
| 4405- | AgNPs, | Silver nanoparticles defeat p53-positive and p53-negative osteosarcoma cells by triggering mitochondrial stress and apoptosis |
| - | in-vitro, | OS, | NA |
| 4362- | AgNPs, | Enhancing Colorectal Cancer Radiation Therapy Efficacy using Silver Nanoprisms Decorated with Graphene as Radiosensitizers |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | HT29 | - | in-vivo, | NA, | NA |
| 4360- | AgNPs, | Silver Nanoparticles as Real Topical Bullets for Wound Healing |
| - | Study, | Nor, | NA |
| 4359- | AgNPs, | Antimicrobial Silver Nanoparticles for Wound Healing Application: Progress and Future Trends |
| - | NA, | Wounds, | NA |
| 4358- | AgNPs, | HPT, | Rad, | Silver nanocrystals mediated combination therapy of radiation with magnetic hyperthermia on glioma cells |
| - | in-vitro, | GBM, | U251 |
| 4447- | AgNPs, | Anti-inflammatory action of silver nanoparticles in vivo: systematic review and meta-analysis |
| - | Review, | Nor, | NA |
| 4379- | AgNPs, | Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells |
| - | in-vitro, | CRC, | LoVo |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:961 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid